Human Investing’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3M Buy
264,084
+10,671
+4% +$819K 2.63% 11
2026
Q1
$19.6M Sell
253,413
-8,714
-3% -$678K 2.85% 9
2025
Q4
$20.4M Buy
262,127
+11,954
+5% +$935K 2.88% 9
2025
Q3
$19.5M Buy
250,173
+19,717
+9% +$1.53M 2.89% 9
2025
Q2
$17.8M Buy
230,456
+8,646
+4% +$659K 2.81% 9
2025
Q1
$17M Buy
221,810
+13,148
+6% +$992K 2.99% 9
2024
Q4
$15.6M Buy
208,662
+5,699
+3% +$433K 2.77% 10
2024
Q3
$15.9M Buy
202,963
+6,959
+4% +$537K 2.88% 9
2024
Q2
$14.7M Buy
196,004
+11,534
+6% +$857K 2.85% 9
2024
Q1
$13.9M Buy
184,470
+8,599
+5% +$648K 2.79% 9
2023
Q4
$13.4M Sell
175,871
-7,286
-4% -$534K 2.9% 9
2023
Q3
$13.2M Buy
183,157
+3,471
+2% +$257K 3.08% 9
2023
Q2
$13.5M Buy
179,686
+5,274
+3% +$402K 3.08% 9
2023
Q1
$13.4M Buy
174,412
+1,438
+0.8% +$109K 3.25% 9
2022
Q4
$12.9M Sell
172,974
-36,617
-17% -$2.71M 3.27% 9
2022
Q3
$15.4M Buy
209,591
+20,862
+11% +$1.61M 3.93% 8
2022
Q2
$14.7M Sell
188,729
-3,559
-2% -$279K 3.54% 8
2022
Q1
$16M Buy
192,288
+12,557
+7% +$1.06M 3.54% 9
2021
Q4
$15.7M Buy
179,731
+8,302
+5% +$737K 3.76% 7
2021
Q3
$15.3M Buy
171,429
+20,176
+13% +$1.83M 3.62% 7
2021
Q2
$13.6M Buy
151,253
+1,278
+0.9% +$114K 3.31% 7
2021
Q1
$13.3M Buy
149,975
+30,326
+25% +$2.75M 3.39% 6
2020
Q4
$11.1M Buy
119,649
+21,608
+22% +$2.01M 3.14% 6
2020
Q3
$9.16M Buy
98,041
+25,799
+36% +$2.42M 3.01% 6
2020
Q2
$6.73M Buy
72,242
+22,134
+44% +$2.03M 2.38% 9
2020
Q1
$4.48M Sell
50,108
-7,634
-13% -$677K 1.94% 9
2019
Q4
$5.04M Buy
57,742
+4,875
+9% +$427K 1.64% 10
2019
Q3
$4.65M Buy
52,867
+2,732
+5% +$239K 1.65% 9
2019
Q2
$4.34M Buy
50,135
+3,097
+7% +$262K 1.58% 9
2019
Q1
$3.95M Sell
47,038
-284
-0.6% -$23.4K 1.48% 10
2018
Q4
$3.85M Buy
+47,322
New +$3.79M 1.6% 9

Other funds holding BIV

Human Investing's BIV Position: Q2 2026 in Review

Human Investing increased its Vanguard Intermediate-Term Bond ETF (BIV) stake by 4.2% in Q2 2026, buying an estimated $819K and bringing the position to 264,084 shares worth $20.3M. The position accounts for 2.63% of the portfolio, ranked #11.

Human Investing first reported a position in BIV in Q4 2018 and has held it in 31 quarters since. The position peaked at $20.4M in Q4 2025. 508 funds tracked by Wall St. Rank hold BIV as of Q2 2026.

  • Human Investing held 264,084 shares of Vanguard Intermediate-Term Bond ETF worth $20.3M as of Q2 2026.
  • Human Investing bought 10,671 Vanguard Intermediate-Term Bond ETF shares in Q2 2026, an estimated $819K.
  • Vanguard Intermediate-Term Bond ETF made up 2.63% of Human Investing's portfolio in Q2 2026, its #11 holding.
  • Human Investing first reported a position in Vanguard Intermediate-Term Bond ETF in Q4 2018 and has held it in 31 quarters since.
  • Human Investing's Vanguard Intermediate-Term Bond ETF position peaked at $20.4M in Q4 2025.
  • 508 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q2 2026.

Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.